ArticleJournal of oncology2022

IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway.

Yanping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.